Unlike normal tissues many tumors cannot synthetize arginine from citrulline due to deficiency of the key urea cycle enzyme, argininosuccinate synthetase 1 (ASS1) and this arginine auxotrophy phenomenon has been explored with anti-cancer treatments that deplete arginine [1–7]. Here, ASS1 is linked to cancer.